Involvement of neurofilaments in motor neuron disease.
Motor neuron disease is clinically characterized by progressive muscle wasting leading to total muscle paralysis. A long history of pathological study of patients has firmly established that the primary lesion site is in spinal and cortical motor neurons. In addition to the wide-spread loss of these neurons, neuronal abnormalities including massive accumulation of neurofilaments in cell bodies and proximal axons have been also widely observed, particularly in the early stages of the disease. To test whether high accumulation of neurofilaments directly contributes to the pathogenic process, transgenic mice that produce high levels of neurofilaments in motor neurons have been generated. These transgenic mice show most of the hallmarks observed in motor neuron disease, including swollen perikarya with eccentrically localized nuclei, proximal axonal swellings, axonal degeneration and severe skeletal muscle atrophy. These data indicate that extensive accumulation of neurofilaments in motor neurons can trigger a neurodegenerative process and may be a key intermediate in the pathway of pathogenesis leading to neuronal loss.
Xu
Z
Z
Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
Cork
L C
LC
Griffin
J W
JW
Cleveland
D W
DW
D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D016472:Motor Neuron Disease / Q000209:etiology / Q000378:metabolism / Q000473:pathology*; D009046:Motor Neurons / Q000378:metabolism / Q000473:pathology; D009133:Muscular Atrophy / Q000473:pathology; D009454:Neurofibrils / Q000378:metabolism / Q000473:pathology*; D016900:Neurofilament Proteins / Q000235:genetics / Q000378:metabolism; D010766:Phosphorylation
D016900:Neurofilament Proteins; C044882:neurofilament protein L; C051774:neurofilament protein H